Correspondence  |   December 2009
Hyperoxia in Pediatric Anesthesia: Time for Reconsideration?
Author Notes
  • University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Article Information
Correspondence   |   December 2009
Hyperoxia in Pediatric Anesthesia: Time for Reconsideration?
Anesthesiology 12 2009, Vol.111, 1383. doi:10.1097/ALN.0b013e3181c0d755
Anesthesiology 12 2009, Vol.111, 1383. doi:10.1097/ALN.0b013e3181c0d755
To the Editor:—
Kalkman et al.  1 link anesthesia to clinically deviant behaviors in children anesthetized for urologic procedures before age 2 yr but make no mention of intraoperative oxygen measurement in their study cohort. Wilder et al.  2 link multiple pediatric anesthetic exposures to learning disabilities using a sophisticated database, albeit one built before pulse oximetry was in wide use. Editorially, Patel and Sun3 provide a review of molecular mechanisms with “relevance” to human development that overlooks the current state of data pertaining to oxygen's neurotoxic effects in cell and animal models. Although all exemplify Engle's proposition that scientists and clinicians must account for how submolecular or molecular actions ramify through a “continuum of natural systems” to produce events at higher systems levels—persons, families, communities, cultures, the biosphere—none acknowledge that early and multiple anesthetic exposure is also a marker for early and multiple oxygen exposure.4,5 
Anesthesiologists and the anesthesia literature, by and large, tend to discount supplemental oxygen effects in patient care in the absence of ischemia–reperfusion injury.6 Others have more balanced views. Maltepe and Saugstad7 note that evolution equips humans with numerous hypoxemia defense responses; hyperoxia, however, always iatrogenic, is not as easily defended against, biologically speaking. Neonatologists know hyperoxia is not always beneficial in neonatal resuscitation.8 Supplemental oxygen use for 3 min or more at birth shows a vexing connection to an increased cancer incidence for children younger than 8 yr.9 The now well established association of retinopathy of prematurity with supplemental oxygen use was incorrectly overlooked for decades.10 
Degos et al.  11 list hypoxia-induced oxidative stress reduction among potential targets for neuroprotective efforts. But significant hypoxemia may be less common than intentional hyperoxia in pediatric anesthesia practice. Even with the classic 70% nitrous oxide–30% oxygen plus volatile anesthetic inhalational induction sequence, hyperoxia exists. Recent bench research using cell cultures and animal models shows that hyperoxia alters cell ultrastructure and function across multiple organelle and neuronal action sites: mitochondria, membrane surfaces, cell nuclei, and progenitor cell lines.12–14 Reactive oxygen species, with other mechanisms, are a source of submolecular injury where hyperoxia is induced experimentally. Such data suggest that neurocidal/neurotoxic potential effects research must account for hyperoxia's submolecular effects, too—effects Engle's model predicts will express at higher levels of biopsychosocial organization.
Endeavors such as Safety of Key Inhaled and Intravenous Drugs in Pediatrics (SAFEKIDS) and General Anesthesia for Effects on Neurodevelopmental Outcome and Apnea in infants (GAS) are much needed.15 Should protocols in future clinical studies include control anesthetics administered at atmospheric or “capped” oxygen partial pressures? Controlled for, hyperoxic effects—known and unknown—might be reasonably addressed as answers emerge to the question, Do anesthetics damage the developing human brain? How else can we gain certainty that iatrogenic hyperoxia does not also play a role in the human developmental adverse outcomes we are now tempted to attribute predominantly to anesthetic agents? Sound science dictates that any known factors that might contribute to pediatric behavioral problems, such as lead, iron, and mercury levels—not just anesthetic exposure—should be taken into account.16 Iatrogenic hyperoxia, sadly, might need to be investigated, too.
University of North Carolina at Chapel Hill, Chapel Hill, North Carolina.
Kalkman CJ, Peelen L, Moons KG, Veenhuizen M, Bruens M, Sinnema G, de Jong TP: Behavior and development in children and the age at the first anesthetic exposure. Anesthesiology 2009; 110:805–12Kalkman, CJ Peelen, L Moons, KG Veenhuizen, M Bruens, M Sinnema, G de Jong, TP
Wilder RT, Flick RP, Sprung J, Katusic SK, Barabresi WJ, Mickelson C, Gleich SJ, Schroeder DR, Weaver AL, Warner DO: Early exposure to anesthesia and learning disabilities in a population-based birth cohort. Anesthesiology 2009; 110:796–804Wilder, RT Flick, RP Sprung, J Katusic, SK Barabresi, WJ Mickelson, C Gleich, SJ Schroeder DR, Weaver, AL Warner, DO
Patel P, Sun L: Update on neonatal anesthetic neurotoxicity: Insight into molecular mechanisms and relevance to humans. Anesthesiology 2009; 110:703–7Patel, P Sun, L
Engel GL: The need for a new medical model: A challenge for biomedicine. Science 1977; 196:129–36Engel, GL
Engle GL: The clinical application of the biopsychosocial model. Am J Psychiatry 1980; 137:535–44Engle, GL
Forkner IF, Piantidosi CA, Scafetta N, Moon RE: Hyperoxia-induced tissue hypoxia: A danger? Anesthesiology 2007; 106:1051–5Forkner, IF Piantidosi, CA Scafetta, N Moon, RE
Maltepe E, Saugstad OD: Oxygen in health and disease: Regulation of oxygen homeostasis—Clinical implications. Pediatr Res 2009; 65:261–8Maltepe, E Saugstad, OD
Vento M, Asensi M, Sastre J, García-Sala F, Pallardó FV, Viña J: Resuscitation with room air instead of 100% oxygen prevents oxidative stress in moderately asphyxiated term neonates. Pediatrics 2001; 107:642–7Vento, M Asensi, M Sastre, J García-Sala, F Pallardó, FV Viña, J
Spector LG, Klebanoff MA, Feusner JH, Georgieff MK, Ross JA: Childhood cancer following neonatal oxygen supplementation. J Pediatr 2005; 147:27–31Spector, LG Klebanoff, MA Feusner, JH Georgieff, MK Ross, JA
Jacobson RM, Feinstein AR: Oxygen as a cause of blindness in premature infants: “Autopsy” of a decade of errors in clinical epidemiologic research. J Clin Epidemiol 1992; 45:1265–87Jacobson, RM Feinstein, AR
Degos V, Loron G, Mantz J, Gressens P: Neuroprotective strategies for the neonatal brain. Anesth Analg 2008; 106:1670–80Degos, V Loron, G Mantz, J Gressens, P
D'Agostino DP, Olson JE, Dean JB: Acute hyperoxia increases lipid peroxidation and induces plasma membrane blebbing in human U87 glioblastoma cells. Neuroscience 2009; 159:1011–22D'Agostino, DP Olson, JE Dean, JB
Chang E, Hornick K, Fritz KI, Mishra OP, Delivoria-Papadopoulos M: Effect of hyperoxia on cortical neuronal nuclear function and programmed cell death mechanisms. Neurochem Res 2007; 32:1142–9Chang, E Hornick, K Fritz, KI Mishra, OP Delivoria-Papadopoulos, M
Koch JD, Miles DK, Gilley JA, Yang CP, Kernie SG: Brief exposure to hyperoxia depletes the glial progenitor pool and impairs functional recovery after hypoxic-ischemic brain injury. J Cereb Blood Flow Metab 2008; 28:1294–306Koch, JD Miles, DK Gilley, JA Yang, CP Kernie, SG
FDA to study anesthetic risks in pediatrics. Anesthesiol News 2009; 35:5
Canfield RL, Henderson CR Jr, Cory-Slecht DA, Cox C, Jusko TA, Lanphear BP: Intellectual impairment in children with blood lead concentrations below 10 μg per deciliter. N Engl J Med 2003; 348:1517–26Canfield, RL Henderson, CR Cory-Slecht, DA Cox, C Jusko, TA Lanphear, BP